Showing 1061-1070 of 4078 results for "".
Take 5: Recent Developments in Systemic Therapy for Psoriasis
https://practicaldermatology.com/columns/recent-developments/take-5-recent-developments-in-systemic-therapy-for-psoriasis/22002/New data reveal noteworthy financial and clinical trends in the use of systemic agents.The Next Frontier: Device-Based Erectile Rejuvenation
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-next-frontier-device-based-erectile-rejuvenation/20828/Low-intensity cutaneous shockwave treatment represents a novel option for the treatment of vasculogenic ED.Analyzing Risk Factors for Subsequent Primary Melanomas
https://practicaldermatology.com/topics/skin-cancer-photoprotection/analyzing-risk-factors-for-subsequent-primary-melanomas/21429/Research Update: Sunscreen Accumulation and Thickness Influence UV Protection
https://practicaldermatology.com/topics/general-topics/study-sunscreen-accumulation-and-thickness-influence-uv-protection/21639/Researchers show specific elements related to sunscreen application affect efficacy.Take 5: Recent Findings in Acne Research
https://practicaldermatology.com/columns/take-5/take-5-recent-findings-in-acne-research/21733/Five new studies examine potentially useful therapies and strategies to improve adherence.Natural Products that Exhibit Antifungal Activity
https://practicaldermatology.com/topics/general-topics/natural-products-that-exhibit-antifungal-activity/20360/Can natural products fight the fungus among us?Erythema Multiforme Major Due to Fluconazole: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/erythema-multiforme-major-due-to-fluconazole-a-case-report/23887/The Biosimilar Revolution: A Look at the Potential Impact
https://practicaldermatology.com/issues/april-2025/the-biosimilar-revolution-a-look-at-the-potential-impact/35596/With many biosimilars expected to gain regulatory approval in coming months and years, Practical Dermatology interviewed Collin Blattner, DO, FAAD—an editorial board member and double-board–certified dermatologist who owns Clearchoice Dermatology, which has 12 locations in Oregon and Washington—abouTreatment of Psychodermatological Conditions Using N-acetylcysteine
https://practicaldermatology.com/columns/physician-spotlight/treatment-of-psychodermatological-conditions-using-n-acetylcysteine/23998/The low risk, high reward of NAC suggests its great promise in a supplementary role for treatment of trichotillomania and excoriation disorder.Verrucous Psoriasis
https://practicaldermatology.com/topics/psoriasis/verrucous-psoriasis/27148/Verrucous psoriasis (VP) is a rare subtype of psoriasis most commonly affecting middle-aged to older adults, with fewer than 35 reported cases within the current literature. It is characterized by symmetric wart-like, hyperkeratotic, papillomatous plaques. Treatment options are limited and variable,